Patents by Inventor Steven Colvin

Steven Colvin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220257956
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 18, 2022
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 11400302
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: August 2, 2022
    Assignee: Shiratronics, Inc.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Patent number: 11357995
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: June 14, 2022
    Assignee: Shiratronics, Inc.
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Publication number: 20220138710
    Abstract: A collaborative ordering and payment method comprising: (a) generating a bill number; (b) ordering one or more items associated with the bill number, wherein the one or more items are ordered by a plurality of users; (c) dividing the ordered items among the plurality of users and calculating an amount owed by each user; and (d) processing payment by one or more of the users to fulfill a total amount owed.
    Type: Application
    Filed: October 26, 2021
    Publication date: May 5, 2022
    Inventor: Steven Colvin
  • Publication number: 20210046319
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Patent number: 10850112
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: December 1, 2020
    Assignee: NUXCEL, INC.
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Publication number: 20200289833
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 10695571
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: June 30, 2020
    Assignee: NUXCEL, INC.
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 10258805
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: April 16, 2019
    Assignee: SYNTILLA MEDICAL, LLC
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin
  • Publication number: 20180236245
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: February 9, 2018
    Publication date: August 23, 2018
    Inventors: HARRY DELLAMANO, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, MICHAEL STEVEN COLVIN, PAUL GRIFFITH, FRANCIS MENEZES
  • Publication number: 20180221664
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: February 6, 2018
    Publication date: August 9, 2018
    Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER, MICHAEL STEVEN COLVIN, CLAIRE DENAULT
  • Patent number: 9889308
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: February 13, 2018
    Assignee: Syntilla Medical LLC
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 9884190
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: February 6, 2018
    Assignee: Syntilla Medical LLC
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Patent number: 9839777
    Abstract: An implantable peripheral neurostimulation lead for head pain is adapted for implantation in the head for the therapeutic purpose of treating chronic head and/or face pain. The lead may include a lead body, a plurality of internal electrically conducting metal wires individually connecting to a proximal surface contact and a distal surface electrode; a distal extended metal surface electrode array; and a proximal in-line connector. The lead may be operable to provide medically acceptable therapeutic neurostimulation to multiple regions of the head, including the frontal, parietal, and occipital regions of the head simultaneously. The lead may include a supraorbital electrode array with electrodes of 3 to 5 mm in length spaced apart at 4 to 6 mm intervals. The lead may also include a temporal electrode array with electrodes of 4 to 6 mm in length spaced apart at 8 to 12 mm intervals.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: December 12, 2017
    Assignee: Syntilla Medical LLC
    Inventors: Kenneth Lyle Reed, Robert Raymond Bulger, Michael Steven Colvin, Claire Denault
  • Publication number: 20170252568
    Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.
    Type: Application
    Filed: May 18, 2017
    Publication date: September 7, 2017
    Inventors: KENNETH LYLE REED, ROBERT RAYMOND BULGER, MICHAEL STEVEN COLVIN
  • Publication number: 20170113054
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Application
    Filed: January 9, 2017
    Publication date: April 27, 2017
    Inventors: HARRY DELLAMANO, KENNETH LYLE REED, ROBERT RAYMOND BULGER, CLAIRE DENAULT, MICHAEL STEVEN COLVIN, PAUL GRIFFITH, FRANCIS MENEZES
  • Patent number: 9568005
    Abstract: A discharge vacuum relief valve kit to provide vacuum relief for a SVRS pump in a hydraulic system is provided. The discharge vacuum relief valve kit includes a vacuum vent tube including a first end and a second end, a discharge vacuum relief valve coupled to the first end of the vacuum vent tube, and a vacuum vent screen coupled to the second end of the vacuum vent tube. The discharge vacuum relief valve is coupled to a drain plug opening of the SVRS pump.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: February 14, 2017
    Assignee: Pentair Water Pool and Spa, Inc.
    Inventors: Ronald B. Robol, Daniel J. Hruby, Johnathan Steven Colvin
  • Patent number: 9539432
    Abstract: A system is provided for driving an implantable neurostimulator lead, the lead having an associated plurality of electrodes disposed in at least one array on the lead. The system comprises an implantable pulse generator (IPG), the IPG including an electrode driver, a load system for determining load requirements, an IPG power coupler, and an IPG communication system. The system also includes an external unit, which includes an external variable power generator, an external power coupler, an external communication system, and a controller for varying the power level of the variable power generator.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: January 10, 2017
    Assignee: Syntilla Medical LLC
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 9498635
    Abstract: An implantable head-mounted, radiofrequency (RF) coupled, unibody peripheral neurostimulation system is provided for implantation in the head for the purpose of treating chronic head pain, including migraine. The system may include an implantable pulse generator (IPG) from which multiple stimulating leads may extend sufficient to allow for adequate stimulation over multiple regions of the head, preferably including the frontal, parietal and occipital regions. A lead may include an extended body, along which may be disposed a plurality of surface metal electrodes (SME), which may be subdivided into a plurality of electrode arrays. A plurality of internal metal wires may run a portion of its length and connect the IPG's internal circuit to the SME. The IPG may include an RF receiver coil and an application specific integrated circuit. The IPG may be capable of functional connection to an external RF unit for purposes that may include power, diagnostics, and programming.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: November 22, 2016
    Assignee: SYNTILLA MEDICAL LLC
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes
  • Patent number: 9498636
    Abstract: A method is provided for controlling power delivery from an external power transfer system (EPTS) to at least one implantable neurostimulator system (INS). The method comprises driving a first transmit coil within the EPTS using a transmit coil driver circuit, receiving, using a receive coil, power transferred from the first transmit coil, coupling the received power to a regulator circuit, monitoring the regulator circuit, communicating a message to the EPTS using a back telemetry circuit, receiving the message, and adjusting the transmit coil driver circuit.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: November 22, 2016
    Assignee: SYNTILLA MEDICAL LLC
    Inventors: Harry Dellamano, Kenneth Lyle Reed, Robert Raymond Bulger, Claire Denault, Michael Steven Colvin, Paul Griffith, Francis Menezes